238 related articles for article (PubMed ID: 30730202)
21. TP53 germline and somatic mutations in a patient with fibrolamellar hepatocellular carcinoma.
Andrade RC; de Lima MAFD; de Faria PAS; Vargas FR
Fam Cancer; 2018 Jan; 17(1):119-122. PubMed ID: 28477317
[TBL] [Abstract][Full Text] [Related]
22. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
Ruijs MW; Verhoef S; Rookus MA; Pruntel R; van der Hout AH; Hogervorst FB; Kluijt I; Sijmons RH; Aalfs CM; Wagner A; Ausems MG; Hoogerbrugge N; van Asperen CJ; Gomez Garcia EB; Meijers-Heijboer H; Ten Kate LP; Menko FH; van 't Veer LJ
J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432
[TBL] [Abstract][Full Text] [Related]
23. p53 Germline mutation in a patient with Li-Fraumeni Syndrome and three metachronous malignancies.
Pötzsch C; Voigtländer T; Lübbert M
J Cancer Res Clin Oncol; 2002 Aug; 128(8):456-60. PubMed ID: 12200603
[TBL] [Abstract][Full Text] [Related]
24. A first report of a rare TP53 variant associated with Li-Fraumeni syndrome manifesting as invasive breast cancer and malignant solitary fibrous tumor.
Prejac J; Dedić Plavetić N; Gotovac Jerčić K; Borovečki F
World J Surg Oncol; 2021 Aug; 19(1):254. PubMed ID: 34452612
[TBL] [Abstract][Full Text] [Related]
25. TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes.
Andrade RC; Dos Santos AC; de Aguirre Neto JC; Nevado J; Lapunzina P; Vargas FR
Fam Cancer; 2017 Apr; 16(2):243-248. PubMed ID: 27714481
[TBL] [Abstract][Full Text] [Related]
26. The first documentation of Li-Fraumeni syndrome in Korea.
Bang YJ; Kang SH; Kim TY; Jung CW; Oh SM; Choe KJ; Kim NK
J Korean Med Sci; 1995 Jun; 10(3):205-10. PubMed ID: 8527048
[TBL] [Abstract][Full Text] [Related]
27. [Li Fraumeni syndrome: a case with multiple primary cancers and presenting a germline p53 mutation].
Landolsi S; Gharbi O; Zrig M; Gribaa M; Njim L; Zakhama A; Abid A; Frébourg T; Ahmed SB
Ann Biol Clin (Paris); 2010; 68(3):346-50. PubMed ID: 20478780
[TBL] [Abstract][Full Text] [Related]
28. Li-Fraumeni syndrome: a case report.
Ilić MP; Kiralj A; Markov B; Mijatov I; Mijatov S; Vučković N
Vojnosanit Pregl; 2014 Dec; 71(12):1159-62. PubMed ID: 25639008
[TBL] [Abstract][Full Text] [Related]
29. Li-Fraumeni syndrome presenting as mucosal melanoma: Case report and treatment considerations.
Klein JD; Kupferman ME
Head Neck; 2017 Feb; 39(2):E20-E22. PubMed ID: 27726232
[TBL] [Abstract][Full Text] [Related]
30. Pediatric Case of Li-Fraumeni Syndrome Complicated with Supratentorial Anaplastic Ependymoma.
Hosoya T; Kambe A; Nishimura Y; Sakamoto M; Maegaki Y; Kurosaki M
World Neurosurg; 2018 Dec; 120():125-128. PubMed ID: 30196175
[TBL] [Abstract][Full Text] [Related]
31. p53 Testing for Li-Fraumeni and Li-Fraumeni-like syndromes.
Gonzalez K; Fong C; Buzin C; Sommer SS; Saldivar JS
Curr Protoc Hum Genet; 2008 Apr; Chapter 10():Unit 10.10. PubMed ID: 18428420
[TBL] [Abstract][Full Text] [Related]
32. [Li-Fraumeni syndrome].
Frebourg T
Bull Cancer; 1997 Jul; 84(7):735-40. PubMed ID: 9339200
[TBL] [Abstract][Full Text] [Related]
33. Li-Fraumeni syndrome: the genetics and treatment considerations for the sarcoma and associated neoplasms.
Upton B; Chu Q; Li BD
Surg Oncol Clin N Am; 2009 Jan; 18(1):145-56, ix. PubMed ID: 19056046
[TBL] [Abstract][Full Text] [Related]
34. New surveillance guidelines for Li-Fraumeni and hereditary TP53 related cancer syndrome: implications for germline TP53 testing in breast cancer.
Evans DG; Woodward ER
Fam Cancer; 2021 Jan; 20(1):1-7. PubMed ID: 32984917
[No Abstract] [Full Text] [Related]
35. Misdiagnosis of Li-Fraumeni Syndrome in a Patient With Clonal Hematopoiesis and a Somatic
Mitchell RL; Kosche C; Burgess K; Wadhwa S; Buckingham L; Ghai R; Rotmensch J; Klapko O; Usha L
J Natl Compr Canc Netw; 2018 May; 16(5):461-466. PubMed ID: 29752319
[TBL] [Abstract][Full Text] [Related]
36. Multiple primary tumors in a family with Li-Fraumeni syndrome with a TP53 germline mutation identified by next-generation sequencing.
Zampiga V; Danesi R; Tedaldi G; Tebaldi M; Cangini I; Pirini F; Pittureri C; Amaducci E; Guidi L; Faedi M; Amadori D; Falcini F; Calistri D
Int J Biol Markers; 2016 Dec; 31(4):e461-e465. PubMed ID: 27516001
[TBL] [Abstract][Full Text] [Related]
37. Genetic and functional analysis of a Li Fraumeni syndrome family in China.
Hu H; Liu J; Liao X; Zhang S; Li H; Lu R; Li X; Lin W; Liu M; Xia Z; Qing G; Li JD
Sci Rep; 2016 Jan; 6():20221. PubMed ID: 26818906
[TBL] [Abstract][Full Text] [Related]
38. [Radiation-induced intracranial osteosarcoma after radiation for acute lymphocytic leukemia associated with Li-Fraumeni syndrome].
Yoshimura J; Natsumeda M; Nishihira Y; Nishiyama K; Saito A; Okamoto K; Takahashi H; Fujii Y
No Shinkei Geka; 2013 Jun; 41(6):499-505. PubMed ID: 23732761
[TBL] [Abstract][Full Text] [Related]
39. Potential of Advexin: a p53 gene-replacement therapy in Li-Fraumeni syndrome.
Nemunaitis JM; Nemunaitis J
Future Oncol; 2008 Dec; 4(6):759-68. PubMed ID: 19086841
[TBL] [Abstract][Full Text] [Related]
40. Association of germline or somatic TP53 missense mutation with oncogene amplification in tumors developed in patients with Li-Fraumeni or Li-Fraumeni-like syndrome.
Sugawara W; Arai Y; Kasai F; Fujiwara Y; Haruta M; Hosaka R; Nishida K; Kurosumi M; Kobayashi Y; Akagi K; Kaneko Y
Genes Chromosomes Cancer; 2011 Jul; 50(7):535-45. PubMed ID: 21484931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]